Literature DB >> 24472724

Novel TRPM8 antagonist attenuates cold hypersensitivity after peripheral nerve injury in rats.

Ryan Patel1, Leonor Gonçalves, Robert Newman, Feng Li Jiang, Anne Goldby, Jennifer Reeve, Alan Hendrick, Martin Teall, Duncan Hannah, Sarah Almond, Nicola Brice, Anthony H Dickenson.   

Abstract

Abnormal cold sensitivity is a common feature of a range of neuropathies. In the murine somatosensory system, multiple aspects of cold sensitivity are dependent on TRPM8, both short term and in response to peripheral nerve injury. The specialized nature of cold-sensitive afferents and the restricted expression of TRPM8 render it an attractive target for the treatment of cold hypersensitivity. This current study examines the effect of a novel TRPM8 antagonist (M8-An) in naive and spinal nerve-ligated rats through behavioral and in vivo electrophysiological approaches. In vitro, M8-An inhibited icilin-evoked Ca(2+) currents in HEK293 cells stably expressing human TRPM8 with an IC(50) of 10.9 nM. In vivo, systemic M8-An transiently decreased core body temperature. Deep dorsal horn recordings were made in vivo from neurons innervating the hind paw. M8-An inhibited neuronal responses to innocuous and noxious cooling of the receptive field in spinal nerve-ligated rats but not in naive rats. No effect on neuronal responses to mechanical and heat stimulation was observed. In addition, M8-An also attenuated behavioral responses to cold but not mechanical stimulation after nerve ligation without affecting the uninjured contralateral response. The data presented here support a contribution of TRPM8 to the pathophysiology of cold hypersensitivity in this model and highlight the potential of the pharmacological block of TRPM8 in alleviating the associated symptoms.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24472724     DOI: 10.1124/jpet.113.211243

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  15 in total

Review 1.  TRPM8 and Migraine.

Authors:  Greg Dussor; Yu-Qing Cao
Journal:  Headache       Date:  2016-09-16       Impact factor: 5.887

Review 2.  ThermoTRPs and Pain.

Authors:  Robyn J Laing; Ajay Dhaka
Journal:  Neuroscientist       Date:  2015-01-21       Impact factor: 7.519

3.  Structure-Based Design of Novel Biphenyl Amide Antagonists of Human Transient Receptor Potential Cation Channel Subfamily M Member 8 Channels with Potential Implications in the Treatment of Sensory Neuropathies.

Authors:  V Blair Journigan; Zhiwei Feng; Saifur Rahman; Yuanqiang Wang; A R M Ruhul Amin; Colleen E Heffner; Nicholas Bachtel; Siyi Wang; Sara Gonzalez-Rodriguez; Asia Fernández-Carvajal; Gregorio Fernández-Ballester; Jacob K Hilton; Wade D Van Horn; Antonio Ferrer-Montiel; Xiang-Qun Xie; Taufiq Rahman
Journal:  ACS Chem Neurosci       Date:  2020-01-09       Impact factor: 4.418

Review 4.  TRPM8 and prostate: a cold case?

Authors:  Lucile Noyer; Guillaume P Grolez; Natalia Prevarskaya; Dimitra Gkika; Loic Lemonnier
Journal:  Pflugers Arch       Date:  2018-06-20       Impact factor: 3.657

Review 5.  TRPM8: a potential target for cancer treatment.

Authors:  Zhaoguo Liu; Hongyan Wu; Zhonghong Wei; Xu Wang; Peiliang Shen; Siliang Wang; Aiyun Wang; Wenxing Chen; Yin Lu
Journal:  J Cancer Res Clin Oncol       Date:  2016-01-23       Impact factor: 4.553

6.  Antinociceptive effect of two novel transient receptor potential melastatin 8 antagonists in acute and chronic pain models in rat.

Authors:  Carmen De Caro; Roberto Russo; Carmen Avagliano; Claudia Cristiano; Antonio Calignano; Andrea Aramini; Gianluca Bianchini; Marcello Allegretti; Laura Brandolini
Journal:  Br J Pharmacol       Date:  2018-04-14       Impact factor: 8.739

7.  AMG2850, a potent and selective TRPM8 antagonist, is not effective in rat models of inflammatory mechanical hypersensitivity and neuropathic tactile allodynia.

Authors:  Sonya G Lehto; Andy D Weyer; Maosheng Zhang; Beth D Youngblood; Judy Wang; Weiya Wang; Patrick C Kerstein; Carl Davis; Kenneth D Wild; Cheryl L Stucky; Narender R Gavva
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-02-10       Impact factor: 3.000

8.  Antibodies to the extracellular pore loop of TRPM8 act as antagonists of channel activation.

Authors:  Silke Miller; Sara Rao; Weiya Wang; Hantao Liu; Judy Wang; Narender R Gavva
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240

9.  Anti-hyperalgesic effects of a novel TRPM8 agonist in neuropathic rats: a comparison with topical menthol.

Authors:  Ryan Patel; Leonor Gonçalves; Mathew Leveridge; Stephen R Mack; Alan Hendrick; Nicola L Brice; Anthony H Dickenson
Journal:  Pain       Date:  2014-07-30       Impact factor: 6.961

10.  Neuronal hyperexcitability in the ventral posterior thalamus of neuropathic rats: modality selective effects of pregabalin.

Authors:  Ryan Patel; Anthony H Dickenson
Journal:  J Neurophysiol       Date:  2016-04-20       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.